RENAISSANCE GROUP LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
RENAISSANCE GROUP LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,092,361
-18.4%
45,496
+2.0%
0.10%
-13.5%
Q2 2023$2,563,679
+45.9%
44,609
-4.8%
0.11%
+37.0%
Q1 2023$1,757,213
+40.6%
46,859
+5.1%
0.08%
+32.8%
Q4 2022$1,249,580
+0.2%
44,596
+0.5%
0.06%
-9.0%
Q3 2022$1,247,000
-16.5%
44,364
+3.3%
0.07%
-13.0%
Q2 2022$1,494,000
-14.8%
42,939
-12.1%
0.08%
-2.5%
Q1 2022$1,753,000
+18.4%
48,833
-23.2%
0.08%
+31.7%
Q4 2021$1,480,000
+28.0%
63,559
+4.5%
0.06%
+20.0%
Q3 2021$1,156,000
-7.2%
60,819
-1.6%
0.05%
-3.8%
Q2 2021$1,246,00061,8270.05%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders